Catherine Schulte
Stock Analyst at Baird
(4.02)
# 572
Out of 4,989 analysts
139
Total ratings
56.41%
Success rate
10.11%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $141 → $142 | $124.38 | +14.17% | 17 | Aug 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,242.28 | -0.99% | 10 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $15 | $12.01 | +24.90% | 13 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $468.00 | +21.15% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $185.91 | +23.18% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.72 | -26.47% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $53.12 | +35.54% | 14 | May 2, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $45.01 | -4.46% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $51.22 | +32.76% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $22.70 | +67.40% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $27.02 | +22.13% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $94.41 | +197.64% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $292.65 | -25.85% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $163.91 | -87.80% | 1 | Jun 28, 2018 |
Agilent Technologies
Aug 28, 2025
Maintains: Outperform
Price Target: $141 → $142
Current: $124.38
Upside: +14.17%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,242.28
Upside: -0.99%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $15
Current: $12.01
Upside: +24.90%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $468.00
Upside: +21.15%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $185.91
Upside: +23.18%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.72
Upside: -26.47%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $53.12
Upside: +35.54%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $45.01
Upside: -4.46%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $51.22
Upside: +32.76%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $22.70
Upside: +67.40%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $27.02
Upside: +22.13%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $94.41
Upside: +197.64%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $292.65
Upside: -25.85%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $163.91
Upside: -87.80%